Search
for
Sort by
Research 421–450 of 654
- Weak correlations between serum and cerebrospinal fluid levels of estradiol, progesterone and testosterone in males
- The leaves of Crataeva nurvala Buch-Ham. modulate locomotor and anxiety behaviors possibly through GABAergic system
- Exploring the Impact of the Microbiome on Neuroactive Steroid Levels in Germ-Free Animals
- A comment on the post-finasteride syndrome
- Anti-nociceptive and anti-inflammatory properties of 5alpha-reductase inhibitor finasteride in experimental animals
- Epigenetic regulation of 5α reductase-1 underlies adaptive plasticity of reproductive function and pubertal timing
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Epigallocatechin-Gallate (EGCG): An Essential Molecule for Human Health and Well-Being
- Proteomic Analysis to Identify Prospective Biomarkers of Treatment Outcome After Microvascular Decompression for Trigeminal Neuralgia: A Preliminary Study
- A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov
- Anabolic–Androgenic Steroids and Brain Damage: A Review of Evidence and Medico-Legal Implications
- Autophagy Controls the Protein Composition of Hair Shafts
- Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis
- The effects of methylated flavonoids on depression-like activity and pro-inflammatory cytokine thresholds in mice induced by repeated finasteride administration
- Antioxidant Constituents of Hops (Humulus lupulus L.) as Functional Raw Materials for Cosmetic Applications
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- Exploration of the Possible Relationships Between Gut and Hypothalamic Inflammation and Allopregnanolone: Preclinical Findings in a Post-Finasteride Rat Model.
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Depression, higher level of tension induction, and impaired coping strategies in response to stress in women with PCOS correlate with clinical and laboratory indices of hyperandrogenism and not with central obesity and insulin resistance
- The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
- Comment on Current Investigations into the Postfinasteride Syndrome
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- Effect of Neurosteroids on Basal and Stress-Induced Oxytocin Secretion in Luteal-Phase and Pregnant Sheep
- Effects of the Usage of l-Cysteine (l-Cys) on Human Health
- Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study
- Treatment of Nonclassic 11-Hydroxylase Deficiency with Ashwagandha Root
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Is Withania somnifera (Ashwagandha) a safe and effective treatment for reducing perimenopausal symptoms?
- Inhibition of neurosteroid synthesis increases asphyxia-induced brain injury in the late gestation fetal sheep
- Effects of Curcumin and Its Different Formulations in Preclinical and Clinical Studies of Peripheral Neuropathic and Postoperative Pain: A Comprehensive Review